School Readiness Program for Sickle Cell Disease

N/A

Recruiting

Led By ANDREW Heitzer, PhD

Research Sponsored by St. Jude Children's Research Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up collected immediately after the intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a school readiness program for young children (ages 4-6) with sickle cell disease. The main goal is to see if this program is feasible and well-received

Who is the study for?

This trial is for preschool children aged 4-6 with sickle cell disease, or their caregivers. It aims to test a school readiness program specifically adapted for these children. Participants should be ready to engage in the study's activities and assessments.

What is being tested?

The trial is testing an adapted Kids in Transition to School Intervention against standard school resources provided to young children with sickle cell disease. The goal is to assess how feasible and acceptable this tailored intervention is.

What are the potential side effects?

Since this trial involves educational and support interventions rather than medical treatments, there are no direct physical side effects expected from participating in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected immediately after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected immediately after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected immediately after the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of Intervention Measure

Feasibility of Intervention Measure

Secondary study objectives

Behavior Rating Inventory of Executive Functioning Preschool or Child

Bracken School Readiness Assessment - 3rd Edition

Head-Toes-Knees-Shoulders Revised

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Readiness InterventionExperimental Treatment1 Intervention

* Attend virtual classroom program sessions- If participants are in the school readiness group, the caregiver, will attend about 8 weeks of sessions virtually with a teacher or social worker and a caregiver of a child with sickle cell, for a total of 8 sessions. The sessions will be during the summer and done in a group. Each session will last about 1 ½ hours and will be video recorded. \> •Complete a caregiver interview-If participants are in the school readiness group, a member of the study team will interview you after the virtual classroom sessions are over. The interview will take about 15-20 minutes and will be audio recorded. Participants will be asked for suggestions and how satisfied you were with the program. * Complete assessments - Caregiver and participant will complete a set of assessments that evaluate school readiness skills (e.g., early math and reading), child behaviors, and parent-child relationships before and after the intervention.

Group II: Control: Standard school resourcesExperimental Treatment1 Intervention

Parents will be provided with information about preschool programs available in the community and age appropriate books for their children

Do I qualify?Apply below to find out